Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2015 R21 RFA-CA-14-003 SARAF, RAVI F UNIVERSITY OF NEBRASKA LINCOLN HIGH SPECIFICITY MICRORNA MICROARRAY ANALYSIS WITHOUT PCR FOR CANCER SCREENING AND RESEARCH Complete
2022 R21 CA21-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies Active
2010 R21 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2014 R21 RFA-CA-13-003 PETRITIS, KONSTANTINOS PHOENIX CHILDREN'S HOSPITAL PRESERVATION OF DRIED PLASMA SPOTS FOR DOWNSTREAM PROTEOMIC APPLICATIONS Complete
2001 R21 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2007 R21 RFA-CA-07-001 HUANG, FAQING UNIVERSITY OF SOUTHERN MISSISSIPPI FOLATE RECEPTOR-MEDIATED SIRNA DELIVERY TO CANCER CELLS Complete
2009 R21 RFA-CA-08-009 FOWLER, CAROL B AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE Complete
2020 R21 RFA-CA-19-019 ALEXANDRAKIS, GEORGIOS UNIVERSITY OF TEXAS ARLINGTON Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy Active
2006 R21 RFA-CA-06-003 FRANKENBURG, SHOSHANA HADASSAH-HEBREW UNIVERSITY MEDICAL CTR TARGETED ANTIGEN DELIVERY FOR CANCER IMMUNOTHERAPY Complete
2012 R21 RFA-CA-12-002 DAVALOS, RAFAEL VIDAL VIRGINIA POLYTECHNIC INST AND ST UNIV ISOLATION OF TUMOR INITIATING CELLS (TICS) USING CONTACTLESS DIELECTROPHORESIS Complete
2019 R21 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Complete
2000 R21 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2002 R21 PAR-99-100 CLEVELAND, WILLIAM L ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS ROBOTIC PREPARATION OF CDNA SINGLE CELLS Complete
2005 R21 RFA-CA-05-003 HYSLOP, TERRY THOMAS JEFFERSON UNIVERSITY NONLINEAR MODELS OF MRNA EXPRESSION IN CANCER BY RT-PCR Complete
2008 R21 RFA-CA-07-035 NELSON, EDWARD L UNIVERSITY OF CALIFORNIA-IRVINE APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E Complete
2011 R21 RFA-CA-10-005 MCDONALD, JOHN F GEORGIA INSTITUTE OF TECHNOLOGY USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE Complete
2015 R21 RFA-CA-14-003 VO-DINH, TUAN DUKE UNIVERSITY NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER Complete
2010 R21 RFA-CA-09-008 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE METHOD FOR DETECTION OF SECRETED PROTEINS IN SINGLE CELL ASSAYS Complete
2001 R21 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
2001 R21 PAR-99-102 ZHOU, PENGBO WEILL MEDICAL COLLEGE OF CORNELL UNIV PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER Complete
2007 R21 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Complete
2022 R21 RFA-CA-21-005 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA Photolithographic Tumor DNA Isolation Active
2000 R21 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2002 R21 PAR-99-100 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CARBON NANOTUBES: ARTIFICAL GELS FOR MUTATIONS DETECTION Complete
2005 R21 RFA-CA-05-003 GREEN, ROLAND D NIMBLEGEN SYSTEMS, INC. MAPPING REGULATORY PATHWAYS IN CANCERS Complete
2008 R21 RFA-CA-07-035 KEELY, PATRICIA J UNIVERSITY OF WISCONSIN-MADISON USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES Complete
2011 R21 RFA-CA-10-005 ZEICHNER, STEVEN L CHILDREN'S RESEARCH INSTITUTE DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS Complete
2015 R21 RFA-CA-14-005 MITRAGOTRI, SAMIR S UNIVERSITY OF CALIFORNIA SANTA BARBARA ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING Complete
2022 R21 CA21-003 BLAINEY, PAUL CLARK BROAD INSTITUTE, INC. Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout Active
2010 R21 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2007 R21 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete
2020 R21 RFA-CA-19-021 GUPTA, GAUTAM UNIVERSITY OF LOUISVILLE Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens Active
2006 R21 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2016 R21 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2000 R21 PAR-99-100 GASCOYNE, PETER RUSSELL CHARLES UNIVERSITY OF TEXAS MD ANDERSON CAN CTR INTEGRATED ISOLATION & MOLECULAR ANALYSIS OF TUMOR CELLS Complete
2002 R21 PAR-99-100 HUANG, TIM H.-M. UNIVERSITY OF MISSOURI-COLUMBIA NOVEL TOOL FOR ANALYSIS OF PROMOTER HYPERMETHYLATION Complete
2005 R21 RFA-CA-05-003 LIZARDI, PAUL M. YALE UNIVERSITY GLOBAL DNA METHYLATION PROFILES OF HEAD AND NECK CANCERS Complete
2008 R21 RFA-CA-07-035 KRON, STEPHEN J UNIVERSITY OF CHICAGO MALDI IMAGING OF CANCER SIGNALING SIGNATURES Complete
2011 R21 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
2022 R21 CA21-005 TANG, SINDY KAM-YAN STANFORD UNIVERSITY A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy Active
2010 R21 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2021 R21 CA20-017 HOSHIKA, SHUICHI FOUNDATION FOR APPLIED MOLECULAR EVOLUTN High Quality Proteins with Multiple Post Translational Modifications Active

Pages